Biohaven Ltd.
BHVN
$14.71
-$0.39-2.58%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 26.72% | 42.17% | -28.74% | -33.21% | -39.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.52% | 100.48% | 116.55% | 123.80% | 19.75% |
| Operating Income | -68.52% | -100.48% | -116.55% | -123.80% | -19.75% |
| Income Before Tax | -71.09% | -106.49% | -68.09% | -70.30% | 5.58% |
| Income Tax Expenses | 144.21% | 153.15% | 96.33% | 61.75% | 70.18% |
| Earnings from Continuing Operations | -71.82% | -107.37% | -73.15% | -73.31% | 4.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.82% | -107.37% | -73.15% | -73.31% | 4.88% |
| EBIT | -68.52% | -100.48% | -116.55% | -123.80% | -19.75% |
| EBITDA | -69.01% | -101.88% | -117.67% | -124.54% | -19.00% |
| EPS Basic | -37.00% | -65.63% | -30.37% | -23.37% | 39.29% |
| Normalized Basic EPS | -33.41% | -60.22% | -66.65% | -60.82% | 25.52% |
| EPS Diluted | -37.00% | -65.63% | -30.37% | -23.37% | 39.29% |
| Normalized Diluted EPS | -33.41% | -60.22% | -66.65% | -60.82% | 25.52% |
| Average Basic Shares Outstanding | 29.20% | 28.13% | 29.47% | 34.30% | 43.58% |
| Average Diluted Shares Outstanding | 29.20% | 28.13% | 29.47% | 34.30% | 43.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |